Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon

Abbott gains key approvals for new steerable delivery sheath

The new device was designed to treat LAA occlusion or closure patients with atrial fibrillation who face a high risk of stroke.

Thumbnail

Surgery still more common than TMVR among AMI patients, but the gap is shrinking

The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy. 

Thumbnail

Presenting with additional chronic conditions can make a big impact on TAVR outcomes

Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  

TAVR, SAVR both beneficial for patients with low-gradient aortic stenosis

The new meta-analysis included data from 32 studies. 

LAAC patients with major bleeding face worse outcomes, longer lengths of stay

The study, published in the American Journal of Cardiology, included data from nearly 20,000 patients treated in 2016 and 2017. 

Thumbnail

13% of TAVR patients develop acute kidney injury, increasing their risk of in-hospital mortality

Chronic kidney disease, congestive heart failure and liver disease are just some of the comorbidities associated with a greater risk of AKI. 

STEMI following TAVR associated with high rates of mortality, PCI failure

The analysis, published in the Journal of the American College of Cardiology, found that post-TAVR STEMI might be rare, but it can lead to substantial complications. 

Thumbnail

Abbott’s TriClip a safe, effective treatment option for severe tricuspid regurgitation

According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%. 

Displaying 601 - 608 of 879
Design by Adaptive Theme